Source: SyncThink
Creators of EYE-SYNC brain health analytics platform bring on Fleener to further mission of objective decision making
Palo Alto, CA—October XX, 2017—A world leader in neuro-technology with foundational in IP in eye-tracking, SyncThink, adds New Orleans’ Saints Tight End, Coby Fleener, to its Athlete Advisory Board. In this advisory capacity, Fleener will contribute to the continued SyncThink mission of bringing an objective brain health solution to the sidelines with EYE-SYNC. EYE-SYNC is designed with VR and eye-tracking technology to objectively measure impairments in just 60 seconds, as well as to assess ocular-motor synchronization deficits and vestibular balance dysfunction. The technology received FDA Clearance last year.
Fleener, of Stanford University and now of the New Orleans Saints, has been in the NFL since 2012 and finished the 2016 season with 50 receptions for 631 yards and three touchdowns. Throughout his football career, he’s seen players struggle with concussion related injuries, and his belief in the EYE-SYNC technology as a solution brought him to this board position.
“I am excited to work with SyncThink because I know first-hand the challenges they are facing and working to solve. The lack of objective measurement for concussions can be frustrating for us athletes, as well as the medical staff trying to keep them healthy,” said Fleener. “SyncThink's solution, EYE-SYNC, uses tested technology and proven methods, and is a tool that should be available to athletes at every level. Objective data provided by the EYE-SYNC platform can go a long way in helping athletes, coaches, and medical staff members make the right return-to-play decisions.”
EYE-SYNC by SyncThink has recently announced partnering with the Stanford University athletics program, Iowa State University, as well as the University of Texas, among others. Fleener contributes an on-field perspective to the technology team with a large-scale university and pro program roll-out already in progress.
“Having known and worked with Coby for almost a decade, I know him to be much more than a star football player,” SyncThink’s Chief Customer Officer Scott Anderson said. “He is thoughtful, intelligent, and cares deeply about impacting the lives of others. I believe this union is the result of a shared vision in which the sidelines and clinics of the future are properly equipped with objective testing measures like ours everywhere you look. Allowing athletes to reach their performance goals by ensuring safety is what we are all about, and it is something Coby works for every day in order to get the most out of his playing career.”
SyncThink works to assist medical professionals in return-to-play and rehabilitation decisions when it comes to brain health assessments. The EYE-SYNC technology is an objective, all-in-one device that can help better protect athletes, and those outside of sports as well.
About SyncThink
SyncThink develops revolutionary eye-tracking technology products, now in VR headsets, that give medical professionals objective metrics for visual attention. Based on 15 years of research and holding over 10 patents, SyncThink’s first product, EYE-SYNC, is a 60-second, objective sideline assessment that uses eye tracking to evaluate for ocular motor impairments and vestibular balance dysfunction – the two most common and serious components of concussion. FDA-cleared for detecting eye-tracking impairment, EYE-SYNC is used by leading university athletic departments and medical clinics, from Stanford University to Massachusetts General Hospital, EYE-SYNC is transforming concussion assessment, recovery, and monitoring. www.syncthink.com
